Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab

NCT05802836 · clinicaltrials.gov ↗

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Severe Hemophilia A
Severe Hemophilia A With Inhibitor
Severe Hemophilia A Without Inhibitor

Interventions

OTHER: no interventions

Sponsor

Christoph Königs

Collaborators

[object Object]
[object Object]